Author: Concert Genetics
Concert and Lyric Partner to Deliver Genetic Test Payment Accuracy in ClaimsXten

Today, Concert is delighted to announce a partnership with Lyric, formerly ClaimsXten Portfolio. Through this partnership, Concert’s genetic test payment accuracy capabilities will be made available through Lyric’s market-leading claim editing solution. This solution addresses a costly challenge for health plans, and for the members they serve. Genetic testing claims are often complex and confusing, […]


Wed. June 7, 2023
Read Post
Concert Genetics Publishes Complete Genetic Testing Reference Policies Integrated with Open, Searchable Test Catalog

Today, Concert Genetics released a complete set of medical policies integrated with its catalog of more than 160,000 genetic testing products. Now, anyone can search by product name or Genetic Testing Unit (GTU) to instantly locate the coverage criteria for any genetic test. “For too long, systemic barriers, such as confusing, conflicting, or inconclusive medical […]


Tue. September 14, 2021
Read Post
Concert Genetics Launches Genetic Test Payment Accuracy Solution for Medicare and Medicare Advantage

Solution delivers payment accuracy and billing compliance in one of Medicare’s highest growth segments NASHVILLE, Tenn. (Aug 26, 2021) – Concert Genetics has launched a genetic testing payment accuracy and compliance solution for Medicare and Medicare Advantage plans. The offering extends Concert’s innovative solution for commercial plans, providing unparalleled test identification, coding consistency, and automated […]


Thu. August 26, 2021
Read Post
Press Release:
Concert Genetics Unveils Comprehensive Genetic Test Identification System to Enable Automation in Precision Medicine

Unique IDs for more than 160,000 genetic testing products released for use in test ordering, authorization, coverage, payment, and clinical decision support NASHVILLE, Tenn. (June 24, 2021) – Concert Genetics has released its comprehensive genetic test identification system for use in the market, enabling a level of automation in test ordering, coverage, payment and clinical […]


Thu. June 24, 2021
Read Post
Press Release:
Concert Genetics Earns Patent for Innovative Methods of Automating Genetic Test Coverage and Payment Accuracy

Concert links 160,000 genetic tests to coverage criteria, automates accurate payment, and supports high-value clinical test ordering NASHVILLE, Tenn. (June 9, 2021) – The U.S. Patent and Trademark Office has issued Concert Genetics patent US10,896,405B1 for innovative methods that enable real-time coverage determination and accurate reimbursement of genetic tests, the company announced today. As the patent […]


Wed. June 9, 2021
Read Post
Press Release:
GeneMatters and Concert Genetics Partner to Scale Tech-Enabled Clinical Genetics Services

Partnership combines scalable technology infrastructure with proven clinical services to help meet the growing demand for genetic care MINNEAPOLIS and NASHVILLE, Tenn. (March 31, 2021) – GeneMatters, a leading provider of telegenetics services and software, and Concert Genetics, a healthcare technology company providing the digital infrastructure for genetic testing management, today announced a partnership to help […]


Wed. March 31, 2021
Read Post
Press Release:
Concert Genetics Launches Preferred Laboratory Network

Invitae, PreventionGenetics, GeneDx first to join network with rigorous quality, service and billing integrity standards NASHVILLE, Tenn. (Jan. 12, 2021) – As part of its ongoing commitment to advance transparency and efficiency in precision medicine, Concert Genetics today announced the launch of a preferred network of genetic testing laboratories. Invitae, PreventionGenetics, and GeneDx Inc., a […]


Tue. January 12, 2021
Read Post
Press Release:
Concert Genetics Unveils End-to-End Genetic Testing Management Program for Health Plans

Concert Genetics Benefit Program combines policy, payment integrity, and a preferred laboratory network to improve quality, reduce complexity, and eliminate manual effort NASHVILLE, Tenn. (Dec. 21, 2020) – Concert Genetics today unveiled the Concert Genetics Benefit Program, an end-to-end genetic testing management solution that enables health plans to provide members with access to high-quality, clinically […]


Mon. December 21, 2020
Read Post
Press Release:
The Burgess Group Selects Concert Genetics to Power Genetic Test Claims Payment Automation

ALEXANDRIA, Va. and NASHVILLE, Tenn. (December 15, 2020) – The Burgess Group (“Burgess”), a HealthEdge company, an innovative payment integrity software company focused on improving healthcare payment operations through technology, has selected Concert Genetics to deliver genetic testing claim edits within the Burgess Source® claims payment automation and business intelligence platform. The solution integrates Concert’s […]


Tue. December 15, 2020
Read Post
Press Release:
Concert Genetics and Trapelo Health Partner to Advance Molecular Oncology Decision Support

Partnership Seeks to Lower Barriers to Evidence-Based Molecular Oncology Care by Extending Trapelo’s Decision Support Solutions Through Concert’s Network of Labs and Health Plans BURLINGTON, Ma. and NASHVILLE, Tenn. (Dec. 10, 2020) – Concert Genetics and Trapelo Health announced today that they have partnered to provide a streamlined, integrated solution that will expand access to evidence-based, […]


Thu. December 10, 2020
Read Post
Integrating Genetics into the Clinical Workflow

As mentioned in an earlier blog post, the Genetic Health Information Network Summit convenes leading from voices across healthcare to share practical challenges and actionable solutions to enable precision medicine. An issue frequently discussed in past Summits (summarized here) is the difficulty of integrating genetics into the clinical workflow. A dizzying array of genetic tests […]


Thu. November 12, 2020
Read Post
Press Release:
Zelis and Concert Genetics Launch Genetic Testing Claim Editing Solution

Companies Provide Pre-payment Solution to Improve Coding and Billing Accuracy BEDMINSTER, NJ and NASHVILLE, TN – September 24, 2020 – Zelis, the healthcare industry’s leading claims cost and payments optimization platform with superior technology and solutions to price, pay and explain claims, and Concert Genetics, a technology company dedicated to advancing precision medicine, have launched […]


Thu. September 24, 2020
Read Post
Overcoming the Challenges of Genetic Test Identification for Billing & Reimbursement

The Genetic Health Information Network Summit has become a forum for influential leaders across healthcare to articulate practical challenges and brainstorm solutions to enable precision medicine. One recurring theme of these events (summarized here) is the ambiguity in the systems used to identify genetic tests for billing, adjudication, and reimbursement. It is no secret that […]


Mon. September 21, 2020
Read Post
Report:
Understanding Genomic Testing Utilization & Coverage in the U.S.

Today, we are pleased to announce the release of a new report: Understanding Genomic Testing Utilization & Coverage in the U.S. Developed in collaboration with the Blue Cross Blue Shield Association, Illumina, and Personalized Medicine Coalition (PMC), this report draws insights about the clinical adoption of genomic testing using health insurance claims and coverage policies. […]


Fri. August 7, 2020
Read Post
Press Release:
Concert Genetics Presents Real-World Data on Utilization of NGS-Based Diagnostic Tests in NCCN 2020 Abstract

NASHVILLE, Tenn. (April 1, 2020) – Concert Genetics, a technology company dedicated to advancing precision medicine, today announced the publication of real-world data on utilization and coding variability in medical claims for Next-Generation Sequencing (NGS)-based diagnostic tests. The study was done in collaboration with Merck, known as MSD outside the United States and Canada, and […]


Wed. April 1, 2020
Read Post
[Webinar]
Precision Medicine for Health Plans

We are pleased to offer this upcoming webinar in collaboration with Burgess and RJ Health. Precision Medicine for Health Plans: Managing coverage and reimbursement amidst the rapid evolution of genetic testing and targeted therapies Wednesday, Feb. 13th 1:00-2:00 pm CT Register here The pace of advancement in genetics and precision medicine is staggering. Today, there […]


Wed. February 6, 2019
Read Post
Press Release:
Concert Genetics Expands Industry Leading Test Order Management Platform to Support Insurance Workflow

The Concert Platform consolidates multiple workflows to streamline communication between clinicians, provider organizations, laboratories and health plans NASHVILLE, Tenn. (Feb. 8, 2018) – Concert Genetics, a technology and managed services company advancing precision medicine, has enhanced its industry leading genetic test order management system to better meet the needs of stakeholders across the healthcare system. […]


Thu. February 8, 2018
Read Post
Announcing The New and Improved Concert Platform

Latest update adds insurance coverage information and other enhancements to the market’s leading genetic test order management platform Earlier today, we announced the release of the latest version of our genetic test ordering management system – The Concert Platform (formerly GeneConnect®) – adding compelling new capabilities to a platform used by leading hospitals and health […]


Thu. February 8, 2018
Read Post
Genetic Test Finder is Better Than Ever

Long-time users of Concert Genetics know we offer a free tool that allows users to search and compare tests from across the entire U.S. clinical genetic testing market. In fact, it’s the #1 genetic test search and comparison tool available. So, what’s new? Today, we released an enhanced version with more (and better) ways to search […]


Fri. January 19, 2018
Read Post
Press Release:
Concert Genetics Completes Growth Financing

Investment capital will enable Concert to expand its offerings focused on the data and digital infrastructure for reliable and efficient management of genetic testing NASHVILLE, Tenn. (Jan. 8, 2018) – Concert Genetics, Inc., announced today it has completed a growth capital financing round with a structured facility led by Deerfield Management. The funds will be […]


Mon. January 8, 2018
Read Post
Press Release:
Genetic Health Information Network Summit Will Address Precision Medicine Challenges

Healthcare leaders organize summit on the data and digital infrastructure needed to enable precision medicine NASHVILLE, Tenn. (May 18, 2017) – Healthcare information technology firm Concert Genetics, in collaboration with leaders from across genetics and healthcare, today announced the first Genetic Health Information Network Summit will take place Sept. 26-27, 2017, in Nashville, Tennessee. The […]


Thu. May 18, 2017
Read Post
Connecting the Genetic Health Information Network (a whitepaper)

At Concert Genetics, we are believers in the promise of precision medicine. In particular, we believe in the role genetics can play in transforming the healthcare system. We’re also pragmatists. Two decades into the genetic revolution, the practical barriers to integrating genetics into the delivery of clinical care are undeniable. The fact is, the infrastructure […]


Thu. May 4, 2017
Read Post
Concert Genetics: Connecting the Future of Healthcare

By Rob Metcalf and Mark Harris, PhD Today we officially launched our company’s new name and brand. We are now Concert Genetics. This is a defining moment for our organization. As we continue to grow, and genetic testing becomes an even more prominent part of the healthcare industry, it’s essential we present a clear picture […]


Wed. March 1, 2017
Read Post
Press Release:
NextGxDx is now Concert Genetics

Healthcare information technology firm working to connect and enable precision medicine NASHVILLE, Tenn. (March 1, 2017) – Healthcare information technology firm NextGxDx Inc. has announced that it is now Concert Genetics. The change is intended to reflect the company’s mission of providing data-driven tools to connect, unify and simplify the world of genetic testing for […]


Wed. March 1, 2017
Read Post
Press Release: Oregon Health & Science University Engages GeneConnect® Genetic Test Utilization Management Solution

NASHVILLE, Tenn. (July 13, 2016) — NextGxDx Inc. (*now Concert Genetics) today announced an agreement with Oregon Health & Science University (OHSU) to deliver GeneConnect®, the genetic test utilization management solution that enables healthcare institutions to lower the costs and address the workflow inefficiencies associated with genetic test ordering. “Genetic testing is the key to […]


Wed. July 13, 2016
Read Post
Press Release: Concert Genetics Founder Mark Harris Names Rob Metcalf as Chief Executive Officer, Assumes New Role as Chief Innovation Officer

NASHVILLE, Tenn. (July 8, 2016) — Mark Harris, Ph.D., today announced Rob Metcalf has succeeded him as chief executive officer of Concert Genetics (*formerly NextGxDx). Harris, who founded the healthcare information technology company in 2010, has elected to take a new leadership position, chief innovation officer, where his primary focus will be developing the next […]


Fri. July 8, 2016
Read Post
Press Release: Dartmouth-Hitchcock Medical Center Engages GeneConnect® Genetic Test Utilization Management Solution

NASHVILLE, Tenn. (June 1, 2016) — NextGxDx Inc. (*now Concert Genetics) today announced an agreement with Dartmouth-Hitchcock Medical Center to deliver GeneConnect®, the genetic test utilization management solution that enables healthcare institutions to lower the costs and address the workflow inefficiencies associated with genetic test ordering. “Genetic testing is the lynchpin of personalized medicine, but […]


Wed. June 1, 2016
Read Post
Press Release: Cincinnati Children’s Engages GeneConnect® Genetic Test Utilization Management Solution

NASHVILLE, Tenn. (December 21, 2015) — NextGxDx Inc. (*now Concert Genetics) today announced an agreement with Cincinnati Children’s Hospital Medical Center to deliver GeneConnect®, the genetic test utilization management solution that enables healthcare institutions to create genetic testing formularies that can lower the costs and address the workflow inefficiencies associated with genetic test ordering. “Genetic […]


Mon. December 21, 2015
Read Post
Press Release: Novation Awards Group Purchasing Agreement to NextGxDx for the Members of Children’s Hospital Association

GeneConnect™ genetic testing utilization software supports management of rapidly rising genetic testing costs NASHVILLE, Tenn., Sept. 16, 2015 /PRNewswire/ — Novation, the nation’s largest healthcare services organization, has awarded a group purchasing contract to Franklin, Tennessee-based NextGxDx, Inc. (*now Concert Genetics) Under the agreement, Children’s Hospital Association (CHA) members who participate with Novation will have […]


Wed. September 16, 2015
Read Post
Press Release: NextGxDx and Seattle Children’s Hospital’s PLUGS® Program Collaborate on Comprehensive Genetic Testing Utilization Management Solution

PLUGS clinical and UM content to be distributed through GeneConnect™ platform SEATTLE, June 25, 2015 /PRNewswire/ — Seattle Children’s Hospital today announced that it will collaborate with NextGxDx, Inc. (*now Concert Genetics) to develop a joint genetic test utilization management (UM) solution for children’s hospitals and pediatric practices. The collaboration will combine the hospital’s PLUGS […]


Thu. June 25, 2015
Read Post